EUVIMEDEUVIMED entdecken
Crossref

Development and validation of a highly sensitive UPLC–MS/MS method for the determination of Huperzine A in rat plasma

Kejun Zhang, Haizhou Wang iD

Biomedical Chromatography · 2024

DOI: 10.1002/bmc.6011 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomedical Chromatography, 2024. Verfasst von Kejun Zhang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Xuzhou New Health Geriatric Hospital, Xuzhou, Jiangsu Province, China. Hauptthemen laut MEDLINE: Sesquiterpenes, Tandem Mass Spectrometry, Alkaloids, Rats, Sprague-Dawley. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Huperzine A is a reversible and selective cholinesterase inhibitor and has been approved for the treatment of Alzheimer's diseases. In this study, we developed a highly sensitive and specific ulta‐high‐performance liquid chromatography–tandem mass spectrometry method for the determination of Huperzine A in rat plasma. An aliquot of 50 μL of rat plasma sample was pretreated with 200 μL of acetonitrile‐methanol ( v/v ; 1:1) containing 0.2% formic acid followed by solid phase extraction. The resulting sample was separated on a Waters ACQUITY BEH C 18 column using acetonitrile and water containing 0.2% formic acid as mobile phase, at a flow rate of 0.3 mL/min. Multiple‐reaction monitoring (MRM) mode was used for quantitative analysis of Huperzine A in positive electrospray ionization. In the concentration range of 0.01–10 ng/mL, Huperzine A showed excellent linearity with correlation coefficient > 0.998. The intra‐ and inter‐day RSD% were less than 9.7%, while the RE% ranged from −6.7% to 10.0%. The mean recovery was >84.5%. The validated method was demonstrated to be selective, sensitive, and reliable, which has been successfully applied to pharmacokinetic study of Huperzine A in rat plasma. Huperzine A displayed a long half‐life in rat plasma and high oral bioavailability.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SesquiterpenesTandem Mass SpectrometryAlkaloidsRats, Sprague-DawleyAnimalsChromatography, High Pressure LiquidRatsReproducibility of ResultsMaleLinear ModelsSensitivity and SpecificityLimit of DetectionLiquid Chromatography-Mass Spectrometry

Stichwörter der Autor:innen

Huperzine AUPLC‐MS/MSpharmacokineticssolid phase extraction

Substanzen

huperzine ASesquiterpenesAlkaloids

Autor:innen und Institutionen

  • Department of Neurology, Xuzhou New Health Geriatric Hospital, Xuzhou, Jiangsu Province, China.

ORCID-Profile: Haizhou Wang

Zitieren

APA

Zhang, K., & Wang, H. (2024). Development and validation of a highly sensitive UPLC–MS/MS method for the determination of Huperzine A in rat plasma. Biomedical Chromatography. https://doi.org/10.1002/bmc.6011

Vancouver

Zhang K, Wang H. Development and validation of a highly sensitive UPLC–MS/MS method for the determination of Huperzine A in rat plasma. Biomedical Chromatography. 2024. doi:10.1002/bmc.6011

BibTeX
@article{Zhang2024,
  author = {Zhang, Kejun and Wang, Haizhou},
  title = {Development and validation of a highly sensitive UPLC–MS/MS method for the determination of Huperzine A in rat plasma},
  journal = {Biomedical Chromatography},
  year = {2024},
  doi = {10.1002/bmc.6011}
}
Kostenlos starten →